Evolent Health

Evolent Health is a population health management services organization that integrates technology, tools and on-the-ground resources to support health systems in executing on their population health and care transformation objectives. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and comprehensive health plan administration services.

Type
Public
HQ
Arlington, US
Founded
2011
Size (employees)
946 (est)
Evolent Health was founded in 2011 and is headquartered in Arlington, US

Key People at Evolent Health

Frank Williams

Frank Williams

CEO
Chad Pomeroy

Chad Pomeroy

CTO

Evolent Health Office Locations

Evolent Health has offices in Arlington, San Francisco, Chicago, Lisle and in 15 other locations
Arlington, US (HQ)
800 N Glebe Rd
Corpus Christi, US
615 N Upper Broadway
Bedford, US
2208 Hwy 121
Austin, US
9601 Amberglen Blvd
Lisle, US
801 Warrenville Rd
Chicago, US
300 S Riverside Plaza
Show all (20)

Evolent Health Data and Metrics

Evolent Health Financial Metrics

Evolent Health's revenue was reported to be $106.2 m in Q1, 2017
USD

Revenue (Q1, 2017)

106.2 m

Gross profit (Q1, 2017)

38.7 m

Gross profit margin (Q1, 2017), %

36%

Net income (Q1, 2017)

(23.1 m)

EBIT (Q1, 2017)

(21.5 m)

Market capitalization (18-Aug-2017)

1 b

Cash (31-Mar-2017)

104.3 m
Evolent Health's current market capitalization is $1 b.
USDFY, 2015FY, 2016

Revenue

96.9 m254.2 m

Revenue growth, %

162%

Cost of goods sold

57.4 m155.2 m

Gross profit

39.5 m99 m

Gross profit Margin, %

41%39%

General and administrative expense

75.3 m160.7 m

Operating expense total

75.3 m160.7 m

EBIT

(43 m)(237.4 m)

EBIT margin, %

(44%)(93%)

Interest expense

293 k723 k

Interest income

723 m

Income tax expense

23.5 m(10.8 m)

Net Income

319.8 m(226.8 m)
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

10.4 m40.4 m49.4 m56.5 m60.2 m106.2 m

Cost of goods sold

7.9 m24.8 m28.6 m32.8 m33.9 m67.5 m

Gross profit

2.5 m15.6 m20.9 m23.7 m26.3 m38.7 m

Gross profit Margin, %

24%39%42%42%44%36%

General and administrative expense

13.1 m29.8 m32.1 m32.8 m38.4 m53.6 m

EBIT

(11.5 m)(17.2 m)(175.2 m)(12.6 m)(15.8 m)(21.5 m)

EBIT margin, %

(111%)(43%)(354%)(22%)(26%)(20%)

Interest income

13 k54 k279 k272 k255 k185 k

Net Income

356.5 m(17.1 m)(173.9 m)(186.3 m)(201.6 m)(23.1 m)
USDFY, 2015FY, 2016

Cash

145.7 m134.6 m

Accounts Receivable

20.4 m40.6 m

Inventories

4.2 m11 m

Current Assets

184.5 m265 m

PP&E

12.8 m31.2 m

Goodwill

608.9 m626.6 m

Total Assets

1 b1.2 b

Accounts Payable

16.7 m43.9 m

Current Liabilities

59.5 m131.9 m

Total Liabilities

287.7 m

Common Stock

415 k506 k

Additional Paid-in Capital

342.1 m555.3 m

Retained Earnings

306.7 m146.6 m

Total Equity

934.6 m912.1 m

Financial Leverage

1.1 x1.3 x
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

219.4 m208.2 m111.3 m105.1 m109.8 m104.3 m

Accounts Receivable

24 m30.5 m25.2 m30.3 m22 m44.6 m

Current Assets

251.6 m246.2 m167.6 m170.6 m191.4 m217.5 m

PP&E

8.5 m10.8 m15.5 m18.5 m21.1 m35.5 m

Goodwill

608.9 m608.9 m459.7 m459.7 m459.7 m627.2 m

Total Assets

1 b1.1 b856.5 m852.8 m851.3 m1.2 b

Accounts Payable

13.5 m12.6 m17 m12.4 m14.5 m39.6 m

Current Liabilities

60.8 m89.8 m52.5 m56.7 m65.3 m104.4 m

Common Stock

415 k415 k426 k426 k448 k570 k

Additional Paid-in Capital

330.8 m335.3 m357 m361.9 m397.6 m621.2 m

Retained Earnings

322.8 m310.8 m183.9 m175.2 m164 m128.6 m

Total Equity

948.7 m936.1 m775.7 m768.1 m759.9 m896.7 m

Financial Leverage

1.1 x1.1 x1.1 x1.1 x1.1 x1.3 x
USDFY, 2015FY, 2016

Net Income

319.8 m(226.8 m)

Inventories

(2 m)(10 m)

Accounts Payable

2.8 m(6.4 m)

Cash From Operating Activities

145.7 m(35.5 m)

Purchases of PP&E

(6.5 m)(15.5 m)

Cash From Investing Activities

(43.7 m)(97.8 m)

Cash From Financing Activities

207.9 m122.1 m
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

356.5 m(17.1 m)(173.9 m)(186.3 m)(201.6 m)(23.1 m)

Depreciation and Amortization

3.4 m

Accounts Receivable

24 m30.5 m

Accounts Payable

13.5 m12.6 m(2.9 m)(3 m)(3.7 m)

Cash From Operating Activities

(20.8 m)(21.9 m)(14 m)(34.8 m)

Purchases of PP&E

(3.4 m)(7.3 m)(11.1 m)(6 m)

Cash From Investing Activities

(13.7 m)(18.5 m)(22.8 m)4.6 m

Cash From Financing Activities

25 k(204 k)879 k(125 k)
USDY, 2017

Revenue/Employee

112.3 k

Financial Leverage

1.3 x

Evolent Health Market Value History

Evolent Health Median Salaries

Source: 80 public H-1B filings from Evolent Health

Traffic Overview of Evolent Health

Evolent Health Online and Social Media Presence

Evolent Health Company Life and Culture

You may also be interested in